Cui, Xinge <br/><br/>
Simultaneous determination of a novel c-Met/AXL dual-target small-molecule inhibitor BPI-9016M and its metabolites in human plasma by liquid chromatography-tandem mass spectrometry: Application in a pharmacokinetic study in Chinese advanced solid tumor patients.  [electronic resource] 

 -  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences  Nov 2017 
 - 33-40 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-376X 
<br/><br/><label>Standard No.: </label>10.1016/j.jchromb.2017.10.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Chromatography, Liquid--methods<br/>Drug Stability<br/>Humans<br/>Linear Models<br/>Neoplasms--drug therapy<br/>Protein Kinase Inhibitors--therapeutic use<br/>Proto-Oncogene Proteins--antagonists & inhibitors<br/>Proto-Oncogene Proteins c-met--antagonists & inhibitors<br/>Receptor Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Reproducibility of Results<br/>Sensitivity and Specificity<br/>Tandem Mass Spectrometry--methods<br/>Axl Receptor Tyrosine Kinase